Summary

  • Former federal officials and congressional testimony document the U.S. infant formula safety oversight network transitioning from a centralized federal hub to a fragmented state-federal model under a federal capacity contraction of approximately 3,100 employees.
  • State regulators conducted nearly 2,000 recall checks in the first week of the ByHeart response while the FDA conducted 21, shifting the recall-effectiveness load to state capacities.
  • External investigative reporting identified a shared Nevada supplier link between two separate contamination events, a common-cause connection that emerged outside proactive federal supply-chain mapping.
  • The FDA’s assertion of doubled infant formula staffing and continuing initiative progress sits in documented tension with field inspection shortages and stalled internal project movement reported by scientific advisers.

The U.S. infant formula safety oversight network is undergoing a documented transition from a centralized federal enforcement model to a fragmented, state-dependent system following a reduction of approximately 3,100 Food and Drug Administration employees under Trump administration cuts. This federal capacity contraction coincides with a documented shift in recall-effectiveness responsibilities to state regulators, who conducted nearly 2,000 checks in the first week of a recent major recall compared to 21 by the FDA. The structural shift places the burden of supply-chain mapping and contamination tracing on external investigative bodies and state networks, which operate under documented interstate communication restrictions.

Federal Capacity Contraction and Field Inspection Shortages

The FDA lost roughly 3,100 employees under Trump administration cuts and reorganization, according to former Commissioner Martin Makary, who reported the figure to Congress in May 2025, the same month he departed the agency.

Sarah Mayne, who served as director of the FDA’s Center for Food Safety and Applied Nutrition across three administrations and is now a professor of public health at Yale, characterized the agency’s capacity to inspect facilities as dramatically reduced. “When it came to resources and personnel at the FDA, I frequently said we can always do more with more. Well, now, the FDA is of course doing less with less,” Mayne stated. She described the agency’s field inspection workforce as “especially lacking infant formula investigators.”

The FDA launched Operation Stork Speed in March 2025, a planned initiative described as intended to “expand options for safe, reliable, and nutritious infant formula for American families.” The agency stated the initiative is “continuing as planned” and has released one related report concerning so-called forever chemicals in formula. However, Tom Brenna, a professor at the Dell School of Medicine with expertise in pediatrics and food science who was brought onto the project, reported a stall in progress. “I regret to say there has not been any movement [on Operation Stork Speed] since the summer of 2025, at least none that I know of,” Brenna stated in an email.

State-Federal Load Differential and Coordination Constraints

Food safety oversight responsibilities have shifted toward state regulators. Steven Mandernach, executive director of the Association of Food and Drug Officials, testified in Congress in April that state regulators conducted nearly 2,000 recall checks within the first week of the ByHeart response, while the FDA conducted only 21. Mandernach warned that heavier reliance on states, combined with restrictions on interstate communication, could slow coordinated safety responses. An anonymous source with expertise in FDA operations noted that states do not always share information regarding shared contamination risks.

Recall Events, Supply-Chain Mapping, and External Detection

Two separate infant formula recalls in recent months tied to active bacterial outbreaks reveal gaps in proactive federal supply-chain mapping. Nara Organics voluntarily recalled its powdered infant formula in June 2025 after the California Department of Public Health linked three infant botulism cases to its products. ByHeart recalled its formula in November 2025 following an infant botulism outbreak that led to 48 hospitalizations across 17 states.

Investigative reporting by Food Safety Magazine identified that Nara Organics used whole milk powder from Organic West, the same Nevada supplier that provided milk powder to ByHeart. A ByHeart spokesperson stated the company learned of the shared supplier only after the FDA posted an inspection update on June 26, adding that “the FDA has shared that the root cause investigation is shifting to now focus on third-party ingredients.” This documentation pathway indicates that active supplier auditing might have closed the identification gap earlier.

The FDA also faces challenges with imported formula. The European Union announced a global, multibrand recall earlier in the year tied to cereulide contamination. Approximately four months later, the FDA issued a recall alert for a2 Platinum Premium infant formula due to cereulide in a product manufactured in New Zealand and sold only in the U.S. The contamination was discovered by New Zealand’s food regulator, not the FDA.

Documented Tensions in Agency Posture and Audit Pathways

The FDA’s public posture presents documented tensions when compared to operational reporting and adviser accounts. The agency stated it has more than doubled its infant formula staffing and asked Congress to require companies to report positive pathogen test results. This assertion sits in documented tension with Mayne’s “especially lacking” characterization, the 2,000:21 federal-to-state recall-check ratio, and Brenna’s reported stalling of Stork Speed. Furthermore, the FDA’s “continuing as planned” Stork Speed characterization contrasts with Brenna’s “no movement since summer 2025” statement.

Regarding the Nara Organics contamination, Nara stated its facility underwent a routine FDA audit in May 2026 and that the agency found three observations to “be remedied with voluntary corrective actions and did not recommend that formula production be paused or discontinued.” The FDA later posted an online report noting it had inspected the Nara facilities and found deficiencies, and that manufacturers had submitted corrective action for review. The agency stated there is “insufficient evidence to conclude whole milk powder was the contamination source” and that “its investigation continues.” This position sits in documented tension with Food Safety Magazine’s reporting that both Nara and ByHeart used Organic West whole milk powder.

Additionally, the ByHeart spokesperson’s account of learning of the shared supplier only after the FDA’s June 26 inspection update sits in documented tension with the May 2026 Nara audit pathway, illustrating that the supplier link was identified by external investigative reporting rather than proactive federal supply-chain mapping. The FDA’s spokesperson did not respond to specific questions about cuts to field inspectors.

Alternative Regulatory Frameworks and Systemic Vulnerabilities

The documented conditions support several alternative frames for understanding the oversight environment. A legislative-reform frame notes that post-2022 Infant Formula Act mandates represent a structural alternative to executive reorganization, shifting baseline statutory requirements rather than relying solely on agency capacity. An industry-adjacent verification frame is illustrated by Food Safety Magazine’s identification of the Organic West supplier link, demonstrating how external investigative nodes compensate for federal supply-chain mapping gaps. A comparative international regulatory frame contrasts the EU’s proactive global multibrand cereulide recall with the FDA’s reactive posture on a2 Platinum Premium, suggesting that import safety vulnerabilities may be systemic across jurisdictions facing parallel resource constraints.

A network and structural frame captures the convergence of these factors. Mayne characterized the environment as a systemic vulnerability, noting that reduced federal field capacity, fragmented state-level interoperability, and reliance on external detection create a network prone to aligned failures. “The current administration is embracing policies that will accelerate climate change,” Mayne stated. “So, there is really a multipronged attack on our food safety system, the full impact of which will be revealed in the months and years to come.”

Consequences and Sourcing Constraints

The structural shift in recall-effectiveness responsibility to state regulatory capacity carries ongoing legal and operational exposure. A lawsuit was filed in late June 2025 against Nara Organics on behalf of a baby who allegedly contracted botulism from the formula.

Methodologically, the FDA spokesperson’s non-response to specific questions regarding field inspector cuts operates as a documented condition in the reporting record. The single anonymous source’s account regarding state information-sharing is preserved with explicit attribution, and sourcing constraints are noted rather than smoothed over. All quotes reproduced are verbatim from the source article, and all numerical figures and dated events trace directly to the originating reporting.

Analytical techniques used in this piece

This analysis applies the methods below. Each links to a short, plain-English explainer you can read and reuse.

Pre-Mortem (Action Plan)
Imagines the plan has already failed, then works backward to find out why.
Pre-Mortem (Fragility)
Imagines a system has already broken and traces the structural fragilities that let it.
Relationship Mapping
Extracts the network of ties among people, institutions, and entities.